Loading company
TMOThermo Fisher Scientific Inc.$259.2BA+Built from Sotera Health Company’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes Sotera Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
$16.31-0.9%Nov 12 close
Figures through September 30, 2026, from the 10-Q filed November 3, 2026
Company outlook: revenue of $1.2B to $1.3B for Fiscal year 2026 — up 6.7% on a year earlier
Just reported
From Sotera Health's results release of November 3, 2026; its quarterly report has since been filed.
Actual
$324.9M
+4.4% y/y
+1.1% q/q
Guided
—
No guide given
Actual
$0.20
+18% y/y
+5.3% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 20 quarters of Sotera Health Company’s grade history. The other 18 go back to March 2022.
